DSOL OTC
Drug Free Solution, Inc.
1W: +0.0%
1M: +0.0%
3M: +100.0%
YTD: -63.6%
1Y: -63.6%
3Y: +300.0%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$7K
+46.5% ▲
Net Income
-$7K
+46.5% ▲
EPS (Diluted)
$0.00
+0.0% ▲
EBITDA
-$7K
+46.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $2K | $805 | $0 | $0 | $0 |
| YoY Growth | +0.0% | -54.4% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $11K | $0 | $0 | $0 | $0 |
| Gross Profit | -$9K | $805 | $0 | $0 | $0 |
| Gross Margin | -522.9% | 100.0% | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1M | $1M | $26K | $13K | $7K |
| Operating Expenses | $1M | $1M | $26K | $13K | $7K |
| Operating Income | -$1M | -$1M | -$26K | -$13K | -$7K |
| Operating Margin | -82066.8% | -174817.4% | — | — | — |
| Interest Expense | $3K | $0 | $0 | $0 | $0 |
| Income Before Tax | -$1M | -$1M | -$26K | -$13K | -$7K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$1M | -$1M | -$26K | -$13K | -$7K |
| Net Margin | -82242.8% | -174816.8% | — | — | — |
| EPS (Diluted) | $-0.01 | $-0.00 | $-0.00 | $0.00 | $0.00 |
| EBITDA | -$1M | -$1M | -$26K | -$13K | -$7K |
| Shares Outstanding | 245M | 428M | 444M | 444M | 283M |